Home Top Movers Why is Reata Pharmaceuticals, Inc. (RETA) stock popping high in Pre-Market trading?

Why is Reata Pharmaceuticals, Inc. (RETA) stock popping high in Pre-Market trading?

Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases, announced that it was communicated from the Division of Neurology Products 1 of the FDA focusing on the preliminary review of briefing materials for an approaching Type C meeting focusing on the development program for omaveloxolone in Friedreich’s ataxia. RETA stock price surged immensely adjacent to the news.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

At last check in premarket trading, shares of Reata Pharmaceuticals Inc. (RETA) were up 14.22% at $94.70. RETA stock closed the last session at $82.91, increasing 4.86% or $3.84. Shares of the company fluctuated between $79.0001 and $85.66 throughout the day. The shares of Reata Pharmaceuticals Inc. have retreated -0.18% in the last five days; however, they have lost -9.09% over the last month.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

About Friedreich’s Ataxia

FA is an uncommon, genetic, life-threatening, and degenerative neuromuscular disorder, which is usually diagnosed during the childhood period. FA is commonly caused by a trinucleotide repeat expansion in the first intron of the frataxin gene, which is responsible for encoding the mitochondrial protein frataxin.

Patients with FA experience several symptoms in adolescence, which may be inclusive of increasing loss of coordination, weakness in muscles, and fatigue, mostly causing motor incapacitation, with patients needing a wheelchair by late teens or early twenties.

FA patients may also experience visual issues, loss in hearing, diabetes, and cardiomyopathy. Based on research, FA affects almost 5,000 children and adults in USA with 22,000 patients worldwide. Presently, there is no approved therapies to treat FA.

About Omaveloxolone

Omaveloxolone is in a development phase, oral, taken once a day, an activator of Nrf2, a transcription factor that stimulates molecular pathways that enhance the resolution of inflammation by bringing back mitochondrial function, diminishing oxidative stress, and limiting pro-inflammatory signaling.

The FDA has complied with an Orphan Drug designation to omaveloxolone to treat Friedreich’s ataxia. The European Commission has granted Orphan Drug designation in Europe to omaveloxolone to treat FA as well.

Reata has gained global rights to develop, produce, and sell omaveloxolone, and our other latest Nrf2 activators. However, omaveloxolone is still an investigational drug, and its safety and tolerance have not been depicted by any agency.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

FDA interest and compliance for reviewal of omaveloxolone to treat FA has immensely increased investor interest with REATA stock price increasing substantially at last check.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

ISun Inc. (ISUN) stock surged during current market trading. Here’s the update

ISun Inc. (NASDAQ: ISUN) stock gained by 19.51% in the current market trading. iSun, based in Burlington, Vermont, is a company built on ideals...

The Trade Desk Inc. (TTD) stock plunged during pre-market. Here’s to know why?

The Trade Desk Inc. (NASDAQ: TTD) stock gained by 0.76% at last close whereas the TTD stock price declines by 90.03% in the pre-market...

Synaptogenix Inc. (SNPX) stock soars during after-hour trading. Why so?

Synaptogenix Inc. (NASDAQ: SNPX) stock gained by 6.33% at last close while the SNPX stock price rises further by 13.48% in the after-hours trading...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update

Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Related News

Edesa Biotech Inc. (EDSA) stock surged during current market trading. Here’s to know why?

Edesa Biotech Inc. (NASDAQ: EDSA) stock gained by 4.22% in the current market trading. Edesa Biotech is a clinical-stage biopharmaceutical business dedicated on the...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Cleveland BioLabs Inc. (CBLI) stock surged during after-hour session. Here’s what’s happening?

Cleveland BioLabs Inc. (NASDAQ: CBLI) stock declined by 3.58% at the last close while the CBLI stock price gains by 17.53% during the after-hour...

Why Ares Commercial Real Estate Corp (ACRE) stock plummeted on Thursday?

Ares Commercial Real Estate Corporation (ACRE) shares slipped 4.35% in after-hours on Thursday, June 17, 2021, and close the trading at $15.60. Earlier, ACRE's...

Nano-X Imaging Ltd. (NNOX) stock gained in the current market trading. Here’s to know why?

Nano-X Imaging Ltd. (NASDAQ: NNOX) stock gained by 14.90% in the current market trading. Nanox which is an Israeli company started by serial entrepreneur...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam